FR2043444A5 - - Google Patents

Info

Publication number
FR2043444A5
FR2043444A5 FR7013770A FR7013770A FR2043444A5 FR 2043444 A5 FR2043444 A5 FR 2043444A5 FR 7013770 A FR7013770 A FR 7013770A FR 7013770 A FR7013770 A FR 7013770A FR 2043444 A5 FR2043444 A5 FR 2043444A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7013770A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH589569A external-priority patent/CH512490A/de
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of FR2043444A5 publication Critical patent/FR2043444A5/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7013770A 1969-04-18 1970-04-16 Expired FR2043444A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH589569A CH512490A (de) 1969-04-18 1969-04-18 Verfahren zur Herstellung von heterocyclischen Verbindungen
CH1326269 1969-09-02

Publications (1)

Publication Number Publication Date
FR2043444A5 true FR2043444A5 (fr) 1971-02-12

Family

ID=25698602

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7013770A Expired FR2043444A5 (fr) 1969-04-18 1970-04-16

Country Status (9)

Country Link
US (1) US3755328A (fr)
JP (1) JPS5416520B1 (fr)
BE (1) BE749072A (fr)
DE (1) DE2017560C2 (fr)
DK (1) DK140373C (fr)
FR (1) FR2043444A5 (fr)
GB (1) GB1298277A (fr)
NL (1) NL176269C (fr)
SE (1) SE361173B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH587858A5 (fr) * 1973-11-28 1977-05-13 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
YU41110B (en) * 1978-07-19 1986-12-31 Lek Tovarna Farmacevtskih Process for preparing dextrorotatory ergot alcaloids acid addition salts
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
BR112013033339A2 (pt) 2011-06-23 2016-08-16 Map Pharmaceuticals Inc análogos de fluorergolina
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
EP2793583A4 (fr) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc Nouveaux composés neuromodulateurs
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH395119A (de) * 1961-05-10 1965-07-15 Sandoz Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CH508628A (de) * 1968-06-25 1971-06-15 Sandoz Ag Verfahren zur Herstellung neuer heterocyclischer Verbindungen

Also Published As

Publication number Publication date
DE2017560A1 (de) 1970-11-05
US3755328A (en) 1973-08-28
NL7005168A (fr) 1970-10-20
GB1298277A (en) 1972-11-29
NL176269B (nl) 1984-10-16
JPS5416520B1 (fr) 1979-06-22
SE361173B (fr) 1973-10-22
DK140373C (da) 1980-01-07
NL176269C (nl) 1985-03-18
DE2017560C2 (de) 1983-11-24
DK140373B (da) 1979-08-13
BE749072A (fr) 1970-10-16

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
HU162310B (fr)
AU442380B2 (fr)
AU442538B2 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU428131B2 (fr)
AU417208B2 (fr)
AU425297B2 (fr)
AU438128B2 (fr)
AU470661B1 (fr)
AU442285B2 (fr)
AU410358B2 (fr)
AU442357B2 (fr)
AU414607B2 (fr)
AU442554B2 (fr)
AU442535B2 (fr)
AU5228269A (fr)
AU5079269A (fr)